WAY-352753

CAS No. 478482-74-5

WAY-352753( —— )

Catalog No. M29008 CAS No. 478482-74-5

WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
2MG 35 In Stock
5MG 55 In Stock
10MG 102 In Stock
25MG 226 In Stock
50MG 328 In Stock
100MG 471 In Stock
200MG 638 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-352753
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
  • Description
    WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    478482-74-5
  • Formula Weight
    303.76
  • Molecular Formula
    C14H10ClN3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1ccccc1CSc1nnc(o1)-c1ccncc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tideglusib

    Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay.

  • CHIR-99021 monohydro...

    A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.

  • GSK-3β inhibitor 1

    GSK-3β inhibitor 1 is an inhibitor of GSK-3β( IC50 of 4.9 nM) and demonstrates high antidiabetic efficacy.GSK-3β inhibitor 1(compound 3a) inhibits GSK-3β with IC50 4.19 nM.?In a cell-based assay 3a shows no significant leucocyte toxicity at 10 M and is moderately cytotoxic against A549 cells.?